Depressed excretion of 6β-hydroxycortisol in lead-toxic children

P. Saenger, Morri E. Markowitz, J. F. Rosen

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

6β-Hydroxycortisol (6βOHF) is a highly polar metabolite of cortisol, probably formed in the endoplasmic reticulum of hepatocytes by cytochrome P-450-dependent microsomal monoxygenases. Lead decreases the activity of cytochrome P-450-dependent microsomal hydroxylases in vivo and in vitro. To examine possible inhibitory effects of lead on 6βOHF metabolism, urinary 6βOHF excretion was measured in 26 children with mild to moderate increases in blood lead concentrations. Children were divided into 2 groups on the basis of their response to the EDTA provocative test. This test was used to assess the size of chelatable and potentially toxic lead stores in such children. Children with elevated urinary lead excretion after an EDTA provocative test, i.e. elevated tissue lead stores, had markedly decreased urinary excretion of 6βOHF (178 ± 15 μg/m2 · 24 h) compared to children who had negative tests (333 ± 40 μg/m2 · 24 h; P < 0.01); their urinary cortisol excretion was not different from that of age-matched controls. These findings suggest that lead, at relatively low concentrations, may interfere with hepatic microsomal formation of a cortisol metabolite.

Original languageEnglish (US)
Pages (from-to)363-367
Number of pages5
JournalJournal of Clinical Endocrinology and Metabolism
Volume58
Issue number2
StatePublished - 1984

Fingerprint

Poisons
Hydrocortisone
Metabolites
Edetic Acid
Cytochrome P-450 Enzyme System
Mixed Function Oxygenases
Lead
Metabolism
Endoplasmic Reticulum
Hepatocytes
Blood
Tissue
Liver

ASJC Scopus subject areas

  • Biochemistry
  • Endocrinology, Diabetes and Metabolism

Cite this

Depressed excretion of 6β-hydroxycortisol in lead-toxic children. / Saenger, P.; Markowitz, Morri E.; Rosen, J. F.

In: Journal of Clinical Endocrinology and Metabolism, Vol. 58, No. 2, 1984, p. 363-367.

Research output: Contribution to journalArticle

@article{d47515f5b5a14a6cbba750acdef4fd2d,
title = "Depressed excretion of 6β-hydroxycortisol in lead-toxic children",
abstract = "6β-Hydroxycortisol (6βOHF) is a highly polar metabolite of cortisol, probably formed in the endoplasmic reticulum of hepatocytes by cytochrome P-450-dependent microsomal monoxygenases. Lead decreases the activity of cytochrome P-450-dependent microsomal hydroxylases in vivo and in vitro. To examine possible inhibitory effects of lead on 6βOHF metabolism, urinary 6βOHF excretion was measured in 26 children with mild to moderate increases in blood lead concentrations. Children were divided into 2 groups on the basis of their response to the EDTA provocative test. This test was used to assess the size of chelatable and potentially toxic lead stores in such children. Children with elevated urinary lead excretion after an EDTA provocative test, i.e. elevated tissue lead stores, had markedly decreased urinary excretion of 6βOHF (178 ± 15 μg/m2 · 24 h) compared to children who had negative tests (333 ± 40 μg/m2 · 24 h; P < 0.01); their urinary cortisol excretion was not different from that of age-matched controls. These findings suggest that lead, at relatively low concentrations, may interfere with hepatic microsomal formation of a cortisol metabolite.",
author = "P. Saenger and Markowitz, {Morri E.} and Rosen, {J. F.}",
year = "1984",
language = "English (US)",
volume = "58",
pages = "363--367",
journal = "Journal of Clinical Endocrinology and Metabolism",
issn = "0021-972X",
publisher = "The Endocrine Society",
number = "2",

}

TY - JOUR

T1 - Depressed excretion of 6β-hydroxycortisol in lead-toxic children

AU - Saenger, P.

AU - Markowitz, Morri E.

AU - Rosen, J. F.

PY - 1984

Y1 - 1984

N2 - 6β-Hydroxycortisol (6βOHF) is a highly polar metabolite of cortisol, probably formed in the endoplasmic reticulum of hepatocytes by cytochrome P-450-dependent microsomal monoxygenases. Lead decreases the activity of cytochrome P-450-dependent microsomal hydroxylases in vivo and in vitro. To examine possible inhibitory effects of lead on 6βOHF metabolism, urinary 6βOHF excretion was measured in 26 children with mild to moderate increases in blood lead concentrations. Children were divided into 2 groups on the basis of their response to the EDTA provocative test. This test was used to assess the size of chelatable and potentially toxic lead stores in such children. Children with elevated urinary lead excretion after an EDTA provocative test, i.e. elevated tissue lead stores, had markedly decreased urinary excretion of 6βOHF (178 ± 15 μg/m2 · 24 h) compared to children who had negative tests (333 ± 40 μg/m2 · 24 h; P < 0.01); their urinary cortisol excretion was not different from that of age-matched controls. These findings suggest that lead, at relatively low concentrations, may interfere with hepatic microsomal formation of a cortisol metabolite.

AB - 6β-Hydroxycortisol (6βOHF) is a highly polar metabolite of cortisol, probably formed in the endoplasmic reticulum of hepatocytes by cytochrome P-450-dependent microsomal monoxygenases. Lead decreases the activity of cytochrome P-450-dependent microsomal hydroxylases in vivo and in vitro. To examine possible inhibitory effects of lead on 6βOHF metabolism, urinary 6βOHF excretion was measured in 26 children with mild to moderate increases in blood lead concentrations. Children were divided into 2 groups on the basis of their response to the EDTA provocative test. This test was used to assess the size of chelatable and potentially toxic lead stores in such children. Children with elevated urinary lead excretion after an EDTA provocative test, i.e. elevated tissue lead stores, had markedly decreased urinary excretion of 6βOHF (178 ± 15 μg/m2 · 24 h) compared to children who had negative tests (333 ± 40 μg/m2 · 24 h; P < 0.01); their urinary cortisol excretion was not different from that of age-matched controls. These findings suggest that lead, at relatively low concentrations, may interfere with hepatic microsomal formation of a cortisol metabolite.

UR - http://www.scopus.com/inward/record.url?scp=0021365978&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0021365978&partnerID=8YFLogxK

M3 - Article

C2 - 6420437

AN - SCOPUS:0021365978

VL - 58

SP - 363

EP - 367

JO - Journal of Clinical Endocrinology and Metabolism

JF - Journal of Clinical Endocrinology and Metabolism

SN - 0021-972X

IS - 2

ER -